Viromed Medical AG VME

RELLINGEN, GERMANY - September 28, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer of cold plasma technology, today published its half-year report for 2026. In the first half of 2...

RELLINGEN, GERMANY - September 2, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, has appointed Prof. Dr. Michael A. Rubhausen to its Medical Advisory B...

RELLINGEN, GERMANY - August 10, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer in cold plasma technology, has entered into several new distribution partnerships for its ViroCAP(R...

RELLINGEN, GERMANY - June 2, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, announces that the multi-year research into the application of cold atmosphe...

RELLINGEN, GERMANY - May 18, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, has entered into a global distribution partnership with NEBU-TEC Internatio...